S. Michael Owens
Oprichter bij InterveXion Therapeutics LLC
Profiel
S.
Michael Owens is the founder of InterveXion Therapeutics LLC, founded in 2004, where he holds the title of Chief Scientific Officer.
He was also the founder of Arkansas Biosciences Institute, founded in 2001, where he held the title of Director in 2002.
Currently, Dr. Owens holds the title of Principal at The University of Arkansas.
Actieve functies van S. Michael Owens
| Bedrijven | Functie | Begin |
|---|---|---|
InterveXion Therapeutics LLC
 InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Oprichter | 17-09-2009 |
| The University of Arkansas | Corporate Officer/Principal | 17-09-2009 |
Eerdere bekende functies van S. Michael Owens
| Bedrijven | Functie | Einde |
|---|---|---|
| Arkansas Biosciences Institute | Oprichter | 01-01-2002 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
| Arkansas Biosciences Institute |
